Fertility Preservation in Female Cancer Patients
Stopped early · Not applicable
Conditions studied: Fertility
In brief
The purpose of this study is to preserve the fertility potential in females diagnosed with cancer by vitrifying (rapidly freezing) their oocytes (eggs) before undergoing treatment for their cancer.
Key facts
- Study ID
- NCT01268592
- Run by
- Northwell Health
- People needed
- 16
- Starts
- 2010-10-01
- Expected to finish
- 2013-03-01
- Last updated by the study team
- 2013-04-23
Who can join
Age: 14 and older, up to 42. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients must be 14-42 year old females with a cancer diagnosis.
- Clearance letter from treating oncologist.
- Approval by program oncologist or her designee.
- Informed consent has to be signed after consultation with the program physician. Minors require consent of a parent or a legal guardian and assent from the participant.
- Life expectancy (predicted by their malignancy) of 5 or more years.
- Cancer diagnosis should have an expected cure rate of 50% or more, based upon clinico-pathologic features.
You may not qualify if…
- Patients whose oncologist and the program oncologist concur that immediate oncologic care should be rendered, not allowing sufficient time for a course of gonadotropin therapy and egg retrieval.
- FSH level >20 MIU/ml, indicating abnormal ovarian function.
- Patients with stage IV cancers (*age appropriate women with stage IV advanced Hodgkin's Lymphoma will be considered, as there is a significant long term survival rate with this advanced disease).
- Patients with incurable cancer diagnoses.
- Patients who are unable or unwilling to sign the informed consent.
- Women cannot have an embryo transfer beyond age 50.
Where it is running
- Center for Human Reproduction — Manhasset, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.